Global GLP-1 Injection Pen Market Research Report 2023

Publication ID:

PB501243704

Publication Date:

January 3, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

GLP-1 (glucagon-like peptide-1) injection pens are medical devices used to administer medications that mimic the action of the naturally occurring hormone GLP-1.
The global GLP-1 Injection Pen market is projected to reach US$ 630 million in 2029, increasing from US$ 452 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029.
Key manufacturers engaged in the GLP-1 Injection Pen industry include Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Tonghua Dongbao Pharmaceutical, Owen Mumford, Gan&Lee Pharmaceuticals and Jiangsu Delfu medical devices, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of GLP-1 Injection Pen were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole GLP-1 Injection Pen market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global GLP-1 Injection Pen market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Tonghua Dongbao Pharmaceutical
Owen Mumford
Gan&Lee Pharmaceuticals
Jiangsu Delfu medical devices
Hanerxi Medical
Segment by Type
Electronic Smart Injection Pen
Mechanical Injection Pen
Segment by Application
Diabetes
Obesity
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The GLP-1 Injection Pen report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 GLP-1 Injection Pen Market Overview
1.1 Product Overview and Scope of GLP-1 Injection Pen
1.2 GLP-1 Injection Pen Segment by Type
1.2.1 Global GLP-1 Injection Pen Market Value Comparison by Type (2023-2029)
1.2.2 Electronic Smart Injection Pen
1.2.3 Mechanical Injection Pen
1.3 GLP-1 Injection Pen Segment by Application
1.3.1 Global GLP-1 Injection Pen Market Value by Application: (2023-2029)
1.3.2 Diabetes
1.3.3 Obesity
1.4 Global GLP-1 Injection Pen Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Injection Pen Revenue 2018-2029
1.4.2 Global GLP-1 Injection Pen Sales 2018-2029
1.4.3 Global GLP-1 Injection Pen Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 GLP-1 Injection Pen Market Competition by Manufacturers
2.1 Global GLP-1 Injection Pen Sales Market Share by Manufacturers (2018-2023)
2.2 Global GLP-1 Injection Pen Revenue Market Share by Manufacturers (2018-2023)
2.3 Global GLP-1 Injection Pen Average Price by Manufacturers (2018-2023)
2.4 Global GLP-1 Injection Pen Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of GLP-1 Injection Pen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Injection Pen, Product Type & Application
2.7 GLP-1 Injection Pen Market Competitive Situation and Trends
2.7.1 GLP-1 Injection Pen Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest GLP-1 Injection Pen Players Market Share by Revenue
2.7.3 Global GLP-1 Injection Pen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GLP-1 Injection Pen Retrospective Market Scenario by Region
3.1 Global GLP-1 Injection Pen Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global GLP-1 Injection Pen Global GLP-1 Injection Pen Sales by Region: 2018-2029
3.2.1 Global GLP-1 Injection Pen Sales by Region: 2018-2023
3.2.2 Global GLP-1 Injection Pen Sales by Region: 2024-2029
3.3 Global GLP-1 Injection Pen Global GLP-1 Injection Pen Revenue by Region: 2018-2029
3.3.1 Global GLP-1 Injection Pen Revenue by Region: 2018-2023
3.3.2 Global GLP-1 Injection Pen Revenue by Region: 2024-2029
3.4 North America GLP-1 Injection Pen Market Facts & Figures by Country
3.4.1 North America GLP-1 Injection Pen Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America GLP-1 Injection Pen Sales by Country (2018-2029)
3.4.3 North America GLP-1 Injection Pen Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Injection Pen Market Facts & Figures by Country
3.5.1 Europe GLP-1 Injection Pen Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe GLP-1 Injection Pen Sales by Country (2018-2029)
3.5.3 Europe GLP-1 Injection Pen Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Injection Pen Market Facts & Figures by Country
3.6.1 Asia Pacific GLP-1 Injection Pen Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific GLP-1 Injection Pen Sales by Country (2018-2029)
3.6.3 Asia Pacific GLP-1 Injection Pen Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Injection Pen Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Injection Pen Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America GLP-1 Injection Pen Sales by Country (2018-2029)
3.7.3 Latin America GLP-1 Injection Pen Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Injection Pen Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Injection Pen Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa GLP-1 Injection Pen Sales by Country (2018-2029)
3.8.3 Middle East and Africa GLP-1 Injection Pen Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Injection Pen Sales by Type (2018-2029)
4.1.1 Global GLP-1 Injection Pen Sales by Type (2018-2023)
4.1.2 Global GLP-1 Injection Pen Sales by Type (2024-2029)
4.1.3 Global GLP-1 Injection Pen Sales Market Share by Type (2018-2029)
4.2 Global GLP-1 Injection Pen Revenue by Type (2018-2029)
4.2.1 Global GLP-1 Injection Pen Revenue by Type (2018-2023)
4.2.2 Global GLP-1 Injection Pen Revenue by Type (2024-2029)
4.2.3 Global GLP-1 Injection Pen Revenue Market Share by Type (2018-2029)
4.3 Global GLP-1 Injection Pen Price by Type (2018-2029)
5 Segment by Application
5.1 Global GLP-1 Injection Pen Sales by Application (2018-2029)
5.1.1 Global GLP-1 Injection Pen Sales by Application (2018-2023)
5.1.2 Global GLP-1 Injection Pen Sales by Application (2024-2029)
5.1.3 Global GLP-1 Injection Pen Sales Market Share by Application (2018-2029)
5.2 Global GLP-1 Injection Pen Revenue by Application (2018-2029)
5.2.1 Global GLP-1 Injection Pen Revenue by Application (2018-2023)
5.2.2 Global GLP-1 Injection Pen Revenue by Application (2024-2029)
5.2.3 Global GLP-1 Injection Pen Revenue Market Share by Application (2018-2029)
5.3 Global GLP-1 Injection Pen Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novo Nordisk GLP-1 Injection Pen Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly GLP-1 Injection Pen Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi GLP-1 Injection Pen Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD GLP-1 Injection Pen Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Ypsomed Holding
6.5.1 Ypsomed Holding Corporation Information
6.5.2 Ypsomed Holding Description and Business Overview
6.5.3 Ypsomed Holding GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ypsomed Holding GLP-1 Injection Pen Product Portfolio
6.5.5 Ypsomed Holding Recent Developments/Updates
6.6 Tonghua Dongbao Pharmaceutical
6.6.1 Tonghua Dongbao Pharmaceutical Corporation Information
6.6.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.6.3 Tonghua Dongbao Pharmaceutical GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tonghua Dongbao Pharmaceutical GLP-1 Injection Pen Product Portfolio
6.6.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.7 Owen Mumford
6.6.1 Owen Mumford Corporation Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Owen Mumford GLP-1 Injection Pen Product Portfolio
6.7.5 Owen Mumford Recent Developments/Updates
6.8 Gan&Lee Pharmaceuticals
6.8.1 Gan&Lee Pharmaceuticals Corporation Information
6.8.2 Gan&Lee Pharmaceuticals Description and Business Overview
6.8.3 Gan&Lee Pharmaceuticals GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Gan&Lee Pharmaceuticals GLP-1 Injection Pen Product Portfolio
6.8.5 Gan&Lee Pharmaceuticals Recent Developments/Updates
6.9 Jiangsu Delfu medical devices
6.9.1 Jiangsu Delfu medical devices Corporation Information
6.9.2 Jiangsu Delfu medical devices Description and Business Overview
6.9.3 Jiangsu Delfu medical devices GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jiangsu Delfu medical devices GLP-1 Injection Pen Product Portfolio
6.9.5 Jiangsu Delfu medical devices Recent Developments/Updates
6.10 Hanerxi Medical
6.10.1 Hanerxi Medical Corporation Information
6.10.2 Hanerxi Medical Description and Business Overview
6.10.3 Hanerxi Medical GLP-1 Injection Pen Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Hanerxi Medical GLP-1 Injection Pen Product Portfolio
6.10.5 Hanerxi Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Injection Pen Industry Chain Analysis
7.2 GLP-1 Injection Pen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Injection Pen Production Mode & Process
7.4 GLP-1 Injection Pen Sales and Marketing
7.4.1 GLP-1 Injection Pen Sales Channels
7.4.2 GLP-1 Injection Pen Distributors
7.5 GLP-1 Injection Pen Customers
8 GLP-1 Injection Pen Market Dynamics
8.1 GLP-1 Injection Pen Industry Trends
8.2 GLP-1 Injection Pen Market Drivers
8.3 GLP-1 Injection Pen Market Challenges
8.4 GLP-1 Injection Pen Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Tonghua Dongbao Pharmaceutical
Owen Mumford
Gan&Lee Pharmaceuticals
Jiangsu Delfu medical devices
Hanerxi Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂